Show Summary Details
Page of

Management of nontoxic multinodular goitre 

Management of nontoxic multinodular goitre
Chapter:
Management of nontoxic multinodular goitre
Author(s):

Wilmar M. Wiersinga

DOI:
10.1093/med/9780199235292.003.3306
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 19 November 2019

Goitres can be classified according to thyroid function into toxic goitres, hypothyroid goitres, and euthyroid or nontoxic goitres (see Chapter 3.5.1). The most prevalent causes of nontoxic goitre are endemic (iodine-deficient) goitre and sporadic nontoxic goitre (diffuse or nodular). The disease entity of sporadic nontoxic goitre is defined as a benign enlargement of the thyroid gland of unknown cause, in euthyroid patients (normal serum free thyroxine (T4) and free triiodothyronine (T3) concentrations) living in an area without endemic goitre. The diagnosis is by exclusion. The prevalence of sporadic nontoxic goitre (also called simple goitre) in the adult population is high, 3.2% in the UK (see Chapter 3.1.7), and it is more common in women (5.3%) than in men (0.8%). This chapter deals predominantly with sporadic nontoxic multinodular goitre.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.